BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35254091)

  • 1.
    Vahedi-Shahandashti R; Dietl AM; Binder U; Nagl M; Würzner R; Lass-Flörl C
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0227421. PubMed ID: 35254091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.
    Blatzer M; Blum G; Jukic E; Posch W; Gruber P; Nagl M; Binder U; Maurer E; Sarg B; Lindner H; Lass-Flörl C; Wilflingseder D
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3778-88. PubMed ID: 25870060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence Studies.
    Jukic E; Blatzer M; Binder U; Mayr L; Lass-Flörl C; Lackner M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.
    Maurer E; Browne N; Surlis C; Jukic E; Moser P; Kavanagh K; Lass-Flörl C; Binder U
    Virulence; 2015; 6(6):591-8. PubMed ID: 26107350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
    Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
    Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species.
    Fakhim H; Badali H; Dannaoui E; Nasirian M; Jahangiri F; Raei M; Vaseghi N; Ahmadikia K; Vaezi A
    J Mycol Med; 2022 Nov; 32(4):101310. PubMed ID: 35907396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus.
    Blum G; Kainzner B; Grif K; Dietrich H; Zeiger B; Sonnweber T; Lass-Flörl C
    Clin Microbiol Infect; 2013 Jan; 19(1):50-55. PubMed ID: 22515428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal resistance in Aspergillus terreus: A current scenario.
    Vahedi Shahandashti R; Lass-Flörl C
    Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into amphotericin B resistance in Aspergillus terreus.
    Blum G; Hörtnagl C; Jukic E; Erbeznik T; Pümpel T; Dietrich H; Nagl M; Speth C; Rambach G; Lass-Flörl C
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1583-8. PubMed ID: 23318794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
    Won EJ; Choi MJ; Shin JH; Park YJ; Byun SA; Jung JS; Kim SH; Shin MG; Suh SP
    PLoS One; 2017; 12(10):e0186086. PubMed ID: 29016668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants.
    Blatzer M; Jukic E; Posch W; Schöpf B; Binder U; Steger M; Blum G; Hackl H; Gnaiger E; Lass-Flörl C; Wilflingseder D
    Antioxid Redox Signal; 2015 Dec; 23(18):1424-38. PubMed ID: 26054424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential basis for amphotericin B resistance in Aspergillus terreus.
    Blum G; Perkhofer S; Haas H; Schrettl M; Würzner R; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1553-5. PubMed ID: 18268082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
    Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich MP; Niederwieser D
    J Antimicrob Chemother; 1998 Oct; 42(4):497-502. PubMed ID: 9818749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.
    Barchiesi F; Spreghini E; Sanguinetti M; Giannini D; Manso E; Castelli P; Girmenia C
    J Antimicrob Chemother; 2013 Nov; 68(11):2587-91. PubMed ID: 23794598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection.
    Hadrich I; Makni F; Neji S; Cheikhrouhou F; Bellaaj H; Elloumi M; Ayadi A; Ranque S
    Med Mycol; 2012 Nov; 50(8):829-34. PubMed ID: 22587728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea.
    Heo MS; Shin JH; Choi MJ; Park YJ; Lee HS; Koo SH; Lee WG; Kim SH; Shin MG; Suh SP; Ryang DW
    Ann Lab Med; 2015 Nov; 35(6):602-10. PubMed ID: 26354348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
    Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
    Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.